companydata.dkcompanydata.dk

Inwound ApS: Financial statements 2025

CVR: 39766612

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Inwound ApS (CVR 39766612) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -4,096,380 and a net result of DKK -7,706,800 compared with DKK -1,025,932 the year before. Equity in the 2025 report amounted to DKK 5,862,914. The solvency ratio was 53.3%. The company had 7 employees in the financial year.

Gross Profit
DKK -4,096,380
Profit/Loss
DKK -7,706,800
Equity
DKK 5,862,914
Total Assets
DKK 10,993,419
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--4.1 mio.-7.7 mio.5.9 mio.7
2024--2 mio.-1 mio.3.5 mio.3
2023--767 t.-2.1 mio.-5.3 mio.2
2022--988 t.-2.3 mio.-4.6 mio.2
2021--857 t.-2.2 mio.-2.2 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Inwound ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Inwound ApS appoints new auditorAug 14, 2025

As of August 14, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of Inwound ApS.

Auditor steps down at Inwound ApSAug 14, 2025

As of August 14, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of Inwound ApS.

Bent von Eitzen joins the board of Inwound ApSJul 14, 2025

As of July 14, 2025, Bent von Eitzen has joined the board of directors of Inwound ApS.

Lasse Blirup Snejbjerg joins the board of Inwound ApSJul 14, 2025

As of July 14, 2025, Lasse Blirup Snejbjerg has joined the board of directors of Inwound ApS.

Torsten Dahl Fredelund joins the board of Inwound ApSJul 14, 2025

As of July 14, 2025, Torsten Dahl Fredelund has joined the board of directors of Inwound ApS.

Carl Morten Bilbo joins the board of Inwound ApSJul 14, 2025

As of July 14, 2025, Carl Morten Bilbo has joined the board of directors of Inwound ApS.

Christopher Bromley joins the board of Inwound ApSJul 14, 2025

As of July 14, 2025, Christopher Bromley has joined the board of directors of Inwound ApS.

Lasse Blirup Snejbjerg leaves the board of Inwound ApSJul 13, 2025

As of July 13, 2025, Lasse Blirup Snejbjerg has left the board of directors of Inwound ApS.

Torsten Dahl Fredelund leaves the board of Inwound ApSJul 13, 2025

As of July 13, 2025, Torsten Dahl Fredelund has left the board of directors of Inwound ApS.

Inwound ApS: The 2024 annual report is outJul 1, 2025

Inwound ApS has published its annual report for 2024. Gross profit came to DKK -1,968,663, and the net result was DKK -1,025,932.

About Inwound ApS

Inwound ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named VulCur MedTech ApS. The management consists of Lasse Blirup Snejbjerg. The board consists of Carl Morten Bilbo (chair), Bent von Eitzen, Christopher Bromley and Lasse Blirup Snejbjerg. The company's owners include WINDING ROADS ApS, Akk Biotek Holding ApS and K Fischer Hansen ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -4,096,380 and a net result of DKK -7,706,800 compared with DKK -1,025,932 the year before. Equity in the 2025 report amounted to DKK 5,862,914.

Source: annual report 2025, Danish Business Authority

Other financial years